vs

Side-by-side financial comparison of Plymouth Industrial REIT, Inc. (PLYM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $51.2M, roughly 1.6× Plymouth Industrial REIT, Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -106.3%, a 68.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -1.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 0.4%).

Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

PLYM vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.6× larger
PRCT
$83.1M
$51.2M
PLYM
Growing faster (revenue YoY)
PRCT
PRCT
+21.6% gap
PRCT
20.2%
-1.4%
PLYM
Higher net margin
PRCT
PRCT
68.2% more per $
PRCT
-38.1%
-106.3%
PLYM
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
0.4%
PLYM

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
PLYM
PLYM
PRCT
PRCT
Revenue
$51.2M
$83.1M
Net Profit
$-54.4M
$-31.6M
Gross Margin
64.9%
Operating Margin
-102.5%
-4.1%
Net Margin
-106.3%
-38.1%
Revenue YoY
-1.4%
20.2%
Net Profit YoY
-248.5%
-27.9%
EPS (diluted)
$-1.23
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLYM
PLYM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$51.2M
$83.3M
Q2 25
$47.2M
$79.2M
Q1 25
$45.6M
$69.2M
Q4 24
$47.6M
$68.2M
Q3 24
$51.9M
$58.4M
Q2 24
$48.7M
$53.4M
Net Profit
PLYM
PLYM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-54.4M
$-21.4M
Q2 25
$-6.1M
$-19.6M
Q1 25
$5.8M
$-24.7M
Q4 24
$147.4M
$-18.9M
Q3 24
$-15.6M
$-21.0M
Q2 24
$1.3M
$-25.6M
Gross Margin
PLYM
PLYM
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PLYM
PLYM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-102.5%
-27.8%
Q2 25
-10.3%
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-29.6%
-38.4%
Q2 24
2.7%
-50.3%
Net Margin
PLYM
PLYM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-106.3%
-25.7%
Q2 25
-12.9%
-24.7%
Q1 25
12.8%
-35.8%
Q4 24
309.9%
-27.6%
Q3 24
-30.1%
-35.9%
Q2 24
2.7%
-48.0%
EPS (diluted)
PLYM
PLYM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-1.23
$-0.38
Q2 25
$-0.14
$-0.35
Q1 25
$0.13
$-0.45
Q4 24
$3.24
$-0.34
Q3 24
$-0.35
$-0.40
Q2 24
$0.03
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLYM
PLYM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$470.1M
$347.7M
Total Assets
$1.6B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLYM
PLYM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
PLYM
PLYM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$646.4M
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PLYM
PLYM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$470.1M
$380.3M
Q2 25
$539.6M
$385.8M
Q1 25
$571.0M
$389.2M
Q4 24
$579.5M
$402.2M
Q3 24
$436.5M
$241.2M
Q2 24
$475.2M
$251.8M
Total Assets
PLYM
PLYM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$1.6B
$511.5M
Q2 25
$1.6B
$513.1M
Q1 25
$1.4B
$519.4M
Q4 24
$1.4B
$534.0M
Q3 24
$1.5B
$374.1M
Q2 24
$1.4B
$374.4M
Debt / Equity
PLYM
PLYM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
1.12×
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLYM
PLYM
PRCT
PRCT
Operating Cash FlowLast quarter
$20.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLYM
PLYM
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$20.0M
$-6.6M
Q2 25
$23.4M
$-15.0M
Q1 25
$15.6M
$-17.0M
Q4 24
$96.1M
$-32.4M
Q3 24
$17.6M
$-18.8M
Q2 24
$19.9M
$-15.7M
Free Cash Flow
PLYM
PLYM
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
PLYM
PLYM
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
PLYM
PLYM
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
PLYM
PLYM
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
2.67×
Q4 24
0.65×
Q3 24
Q2 24
15.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PLYM
PLYM

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons